Tagged with Samsung

Samsung Bioepis: Building a US Biosimilar Market That Lasts
Generics and Biosimilars in the US: Margins, Market Access, & the Patent Expiry Wave
Global Biosimilar Market Trends 2026: Europe Under Pressure, America Awakening, Crucial Korea
Tom Newcomer – SVP & Head of US Commercial, Samsung Bioepis
Biosimilars Trends to Know in 2025: Europe’s Dominance, South Korea’s Rise, and the Growing Development Gap
Top 10 CDMOs 2024
South Korea Pharma News: Merck Builds New $326 Million Plant; EuBiologics Gets Cholera Vaccine Prequalification
Top Biologics CDMOs 2023
Samsung Biologics Rides CDMO Expansion Wave with New USD 1.5 Billion Korean Investment
PharmaBoardroom’s 10 Most Read Interviews of 2022
On Track for a Major Share of Global Pharma Manufacturing
Top Global CDMOs 2022
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here